AbbVie Inc. planned insider sales
In the last twelve months insiders at AbbVie Inc. filed 5 Form 144 notices of planned sales, 91,989 shares worth $21.7 million at the time of filing, from 4 sellers. The latest, filed 14 August 2026: Nicholas Donoghoe (officer), 32,710 shares worth $8.2 million, planned for around 14 August 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 14 August 2026 | Nicholas Donoghoe | Officer | 32,710 | $8.2 million | 14 August 2026 | 32,710 shares from 14 August 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
| 26 May 2026 | Robert J Alpern | Director | 13,000 | $2.8 million | 26 May 2026 | No matching Form 4 sale | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock | Form 144 |
| 6 March 2026 | David R. Purdue | Officer | 5,230 | $1.2 million | 4 March 2026 | No matching Form 4 sale | Morgan Stanley Smith Barney LLC | Performance Shares; Restricted Stock | Form 144 |
| 2 March 2026 | Perry C Siatis | Officer | 18,668 | $4.4 million | 2 March 2026 | 18,668 shares from 2 March 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Performance Shares | Form 144 |
| 25 February 2026 | Perry C Siatis | Officer | 22,381 | $5.1 million | 25 February 2026 | 22,381 shares from 25 February 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.